Experimental heterotopic heart transplantation without ischemia or reperfusion

Area of Science:

• Cardiovascular Surgery
• Transplantation Immunology
• Organ Preservation

Background:

• Current heart transplantation models involve ischemia, leading to myocardial damage.
• Ischemia causes rhythm disturbances, myocardial distention, and reperfusion injury.
• A need exists for improved experimental models that minimize donor heart injury.

Purpose of the Study:

• To develop and validate a novel cervical heterotopic heart transplantation model.
• To eliminate ischemia and reperfusion injury in experimental heart transplantation.
• To provide a platform for evaluating pretreatment regimens in transplanted hearts.

Main Methods:

• Developed a cervical heterotopic heart transplantation technique utilizing retrograde perfusion.
• Avoided ischemic time by employing continuous perfusion during donor heart harvest and transport.
• Performed over 100 successful transplantations for control and experimental protocols.

Main Results:

• Successfully established a reproducible model of cervical heterotopic heart transplantation.
• Demonstrated avoidance of ischemia and reperfusion injury in the transplanted hearts.
• Prevented myocardial damage associated with overdistention during preservation.

Conclusions:

• The retrograde perfusion cervical heterotopic heart transplantation model effectively mitigates ischemia and reperfusion injury.
• This model offers significant advantages over traditional methods for heart transplantation research.
• The technique facilitates the evaluation of interventions aimed at improving graft survival and function.